Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nonpsychotropic cannabinoid receptors regulate microglial cell migration.

Lisa Walter1, Allyn Franklin, Anke Witting

  • 1Department of Pharmacology, University of Washington, Seattle, Washington 98195-7280, USA.

The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|February 25, 2003
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Aquaporin 9 regulates acetaldehyde uptake, alcohol-induced liver injury, and drinking behavior.

Alcohol, clinical & experimental research·2026
Same author

Monlunabant in adults with obesity and metabolic syndrome: Open-label extension of a phase 2a trial.

Diabetes, obesity & metabolism·2026
Same author

A double-blind, randomized, placebo-controlled, phase 2 trial examined the efficacy and safety of monlunabant in adults with diabetic kidney disease.

Kidney international·2026
Same author

Hepatic Aquaporin 8 Promotes Alcohol Consumption and Ameliorates Alcohol-Induced Liver Injury by Facilitating Acetaldehyde Excretion.

International journal of biological sciences·2026
Same author

Efficacy and safety of monlunabant in adults with obesity and metabolic syndrome: a double-blind, randomised, placebo-controlled, phase 2a trial.

The lancet. Diabetes & endocrinology·2025
Same author

CB<sub>1</sub> receptors on a subset of vagal afferent neurons modulate voluntary ethanol intake in mice.

Molecular psychiatry·2025

The endocannabinoid 2-arachidonylglycerol (2-AG) drives microglial cell migration during neuroinflammation. Nonpsychotropic compounds like cannabinol and cannabidiol may block this process, offering therapeutic potential for inflammatory brain conditions.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Pharmacology

Background:

  • Microglial cells are key players in neuroinflammation, migrating to damaged neurons and potentially worsening injury.
  • The molecular signals initiating microglial migration remain largely unknown.
  • Understanding these signals is crucial for developing targeted neuroprotective therapies.

Purpose of the Study:

  • To identify signaling molecules that trigger microglial cell migration towards damaged neurons.
  • To investigate the role of endocannabinoids, specifically 2-arachidonylglycerol (2-AG), in this process.
  • To explore the therapeutic potential of nonpsychotropic cannabinoids in modulating microglial migration.

Main Methods:

  • Pathological stimulation of neurons and microglial cells with glutamate, carbachol, and ATP.

Related Experiment Videos

  • Measurement of endocannabinoid production using biochemical assays.
  • Boyden chamber assay to assess microglial cell migration.
  • Pharmacological inhibition and antagonism of cannabinoid receptors (CB2, abnormal-cannabidiol-sensitive).
  • Analysis of extracellular signal-regulated kinase 1/2 (ERK1/2) pathway activation.
  • Immunofluorescence to detect CB2 receptor localization on microglial cells.

    • Main Results:

    • Pathological neuronal and microglial stimulation significantly increased 2-AG production.
    • 2-AG was identified as a potent inducer of microglial cell migration.
    • Microglial migration induced by 2-AG involved CB2 and abnormal-cannabidiol-sensitive receptors and ERK1/2 signaling.
    • Cannabinol and cannabidiol effectively inhibited 2-AG-induced microglial migration by antagonizing these receptors.
    • CB2 receptors were localized at the leading edge of microglial lamellipodia, supporting their role in migration.

    Conclusions:

    • A cannabinoid signaling system, primarily involving 2-AG and CB2 receptors, regulates microglial cell migration.
    • This 2-AG-mediated pathway is implicated in recruiting microglial cells to sites of neuroinflammation.
    • Cannabinol and cannabidiol represent promising nonpsychotropic therapeutic agents to mitigate detrimental microglial recruitment in neuroinflammatory conditions.